Overview
- The permanently changing nature of hormone therapy with new pharmaceutical products and especially, new and challenging concepts on applying them will be addressed
- The book will include clinical and pathological descriptions, theoretical and practical medical issues with important impact on women's health
- The book will include both oncologic and fertility aspects of gynecological pathology
Part of the book series: Advances in Experimental Medicine and Biology (AEMB, volume 1242)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (8 chapters)
-
Front Matter
-
Back Matter
Keywords
About this book
Hormonal influences, both natural and iatrogenic, are implicated in the most frequent health issues of women. Endometrial cancer is now the most common gynecologic cancer in the United States and the industrialized world. This cancer is strongly related to hormonal and metabolic factors. In addition, breast cancer treated with hormone therapy (Tamoxifen) may, in some cases, be associated with uterine pathology. Hormone therapy is used to improve the physiological effects and counteract abnormal and deleterious effects of “natural” hormonal activity. Millions of women receive hormone therapy at some point of their life: using oral contraceptives, reproductive technology, treatment for post-menopausal symptoms, among other uses.
This book addresses a range of women’s health issues, from fertility to neoplasms, and their relationship with natural and iatrogenic hormonal effects. Chapters include clinical and pathological descriptions, theoretical and practical medical issues, and original studies and cases. Controversial issues in certain hormone therapies are presented with updated concepts based on clinical studies and novel statistical methods. The book will be useful for specialized and general physicians, oncologists, endocrinologists, researchers, medical students, and others in the field of women’s health.
Editors and Affiliations
About the editors
Dr. Angelica Mareş Miceli graduated from Medical School in Bucharest, Romania, trained in Pathology in Bucharest and New York, then specialized in Gynecologic Pathology and Cytopathology at Mount Sinai Hospital in New York, under the mentorship of Dr Liane Deligdisch-Schor. Their research collaboration started more than fifteen years ago. Presently, Dr Mareş Miceli works in the field of GynecologicPathology and teaching in Pathology/ Pathophysiology Program at New York Medical College – School of Medicine. Her work includes diagnosis, clinical-pathologic correlation, teaching students and pathology residents, research on ovarian dysplasia and carcinoid ovarian tumors, and publishing; her interests are early diagnosis and the study of cancer precursors in gynecologic neoplasms, pediatric, adolescent and young adult gynecology. Dr. Mareş Miceli is involved in many academic activities, being a member in numerous committees for education and curriculum, promotions and career advisor; she received many awards for teaching and is often invited as speaker at national and international meetings. She is also an enthusiastic nature and art lover.
Bibliographic Information
Book Title: Hormonal Pathology of the Uterus
Editors: Liane Deligdisch-Schor, Angelica Mareş Miceli
Series Title: Advances in Experimental Medicine and Biology
DOI: https://doi.org/10.1007/978-3-030-38474-6
Publisher: Springer Cham
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2020
Hardcover ISBN: 978-3-030-38473-9Published: 14 May 2020
Softcover ISBN: 978-3-030-38476-0Published: 14 May 2021
eBook ISBN: 978-3-030-38474-6Published: 13 May 2020
Series ISSN: 0065-2598
Series E-ISSN: 2214-8019
Edition Number: 1
Number of Pages: VIII, 185
Number of Illustrations: 7 b/w illustrations, 59 illustrations in colour
Topics: Cancer Research, Endocrinology, Pathology